Free lookups: 1/3 Unlock Pro
Clinical reference Find a medicine
Ctrl K
1 of 3 free lookups remaining Upgrade
New search Medicine profile Water, Aloe Barbadensis Extract, Triethanolamine, Carbomer, Geranium Thunbergii Extract, Pogostemon Cablin Leaf Extract

Clinical medicine profile

Water, Aloe Barbadensis Extract, Triethanolamine, Carbomer, Geranium Thunbergii Extract, Pogostemon Cablin Leaf Extract

Traditional / herbal topical & internal (regulated as herbal product)

OTC
Evidence state Source-linked Review date not recorded
Route
Topical; oral latex (laxative — caution)
Schedule
OTC
ATC
Not assigned
PPB status
registered
Patient advice Check interactions
01 Risk first

Safety essentials

The information most likely to change a prescribing or dispensing decision.

Contraindications

  • Hypersensitivity to the active substance or excipients.
  • Additional absolute contraindications are indication- and product-specific — consult SmPC.

Precautions

  • Warnings • FLAMMABLE.
  • DO NOT USE NEAR HEAT, FLAME, OR WHILE SMOKING.
  • CAN CAUSE SERIOUS INJURY OR DEATH • Keep away from face and mouth to avoid breathing in. • Avoid spraying in eyes.
  • Contents under pressure.
  • Do not puncture or incinerate.
  • Do not expose to heat or store at temperatures above 120°F/50°C or in enclosed places that could overheat • Do not use on broken skin.
  • Stop use if rash or irritation occurs. • Ask a doctor before using if you have kidney disease. • USE ONLY AS DIRECTED.
  • INTENTIONAL MISUSE BY DELIBERATELY CONCENTRATING AND INHALING THE CONTENTS CAN BE HARMFUL OR FATAL.
  • Help stop inhalation abuse.
  • For information visit www.inhalant.org
02 Point of care

Dosing matrix

Population and organ-function guidance, shown together for faster comparison.

Adult

Directions: Newborn, 0.5 ml tthree times per day or as needed. 6 months, 1.0 ml three times per day or as needed. To be used according to standard homepoathic indications

Paediatric

Topical on intact skin only with care; avoid oral latex in children.

Renal

Review renal impairment dosing; many agents need CrCl/eGFR adjustment.

  • CrCl 0–120: Confirm renal dosing in product SmPC / primary label.
Hepatic

Review hepatic impairment dosing; monitor LFTs if agent is hepatically cleared or hepatotoxic.

03 Clinical use

Use, effects & interactions

Indications

  • Treatment and prevention of hemorrhoids (internal and external), fissures, and anal discomforts Clinical selection for Water, Aloe Barbadensis Extract, Triethanolamine, Carbomer, Geranium Thunbergii Extract, Pogostemon Cablin Leaf Extract should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC.
  • Class context: Traditional / herbal topical & internal (regulated as herbal product).
  • Confirm site-specific dose, duration and monitoring before prescribing.

Adverse effects

  • Adverse reactions vary by agent.
  • Counsel on common predictable effects and serious warning symptoms (allergy, severe rash, jaundice, unusual bleeding, severe GI symptoms, neurological changes).
  • Report suspected ADRs via national pharmacovigilance channels.
  • Professional use: confirm indication, dose, duration, monitoring and patient counselling points against current Kenya STG / EML and the product SmPC.
  • Document allergy status and key interactions.
04 Pharmacology

Mechanism & disposition

Gel: moisturising/soothing polysaccharides.

Gel: moisturising/soothing polysaccharides…Latex: anthraquinone stimulant laxative ef…Mechanism is agent-specific.
Read complete mechanism

Gel: moisturising/soothing polysaccharides. Latex: anthraquinone stimulant laxative effect. Mechanism is agent-specific. At receptor, enzyme, ion channel, transporter or microbial target level, the drug alters a physiological or pathological pathway to produce its therapeutic effect. Confirm precise molecular mechanism in current SmPC / pharmacology reference for this INN before high-stakes decisions.

Onset

Product-specific

Duration

Product-specific

Route

Topical; oral latex (laxative — caution)

Elimination

are product-specific. Consider food effects, protein binding, hepatic CYP/UGT

Half-life

when adjusting for organ impairment, age and drug interactions. Verify parameters in the current SmPC.

05 Special populations

Pregnancy, lactation & diet

Pregnancy

Use only if potential benefit justifies potential risk; prefer agents with better reproductive data when alternatives exist.

Lactation

Assess infant risk vs benefit of maternal therapy; prefer agents with lactation data.

06 Kenya market

Brands & loaded prices

From
Median
Listings0
BrandManufacturerPackObserved price
No reviewed brand listings are linked yet.
07 Provenance

Sources & review state

Primary sourceLocal active-ingredient clinical extract; FDA drug label via OpenFDA/DailyMed; KEMRI traditional medicine landscape; PPB Guidelines for registration of herbal products (2022)
Last reviewedNot recorded
EvidenceSource-linked
Open source document ↗

Decision support only. Confirm patient-specific decisions against the current product SmPC, Kenya STG/EML, and professional judgement.